FilingIndex
10-KThe Record

Xeris Biopharma Holdings, Inc. files 10-K

Filed Mar 8, 2023 · 3y ago · Accession 0001867096-23-000031

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
XERS
CIK
1867096
Form type
10-K
Filing date
Mar 8, 2023
Report date
Dec 31, 2022
Document
xers-20221231.htm
Size
25.0 MB